Tag: PEP
20
OctoberRaltegravir for Post-Exposure Prophylaxis: Is It a Viable Option?
Raltegravir is still used for HIV post-exposure prophylaxis, but dolutegravir is now preferred due to simpler dosing and better adherence. Learn when raltegravir remains the right choice.
Recent posts
-
26 Oct 2025
Nitroglycerin vs Alternatives: What Works Best for Angina and Heart Pain
-
21 Feb 2026
Side Effects and Medication Adherence: How to Stay on Track When Pills Make You Feel Worse
-
28 Jan 2026
Melanoma: How Early Detection and Immunotherapy Are Saving Lives in 2026
-
13 Jan 2026
Prediabetes Diet: How Fiber, Protein, and Glycemic Index Can Stop Type 2 Diabetes
-
1 Dec 2025
Omeprazole and Clopidogrel: How CYP2C19 Inhibition Affects Heart Drug Effectiveness